A phase II trial of IRX4204 in multiple sclerosis.
Phase of Trial: Phase II
Latest Information Update: 01 Oct 2016
At a glance
- Drugs IRX 4204 (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 01 Oct 2016 Trial focus is assumed. There can multiple trials,as the MR states phase II trials. At present created profile for one trial.
- 01 Oct 2016 New trial record